6-hydroxy-2-methylmercaptobenzoxazole | 74537-54-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 英文名称: 6-hydroxy-2-methylmercaptobenzoxazole
• 英文别名: 6-hydroxy-2-methylthiobenzoxazole；2-Methylthiobenzoxazol-6-ol；2-methylsulfanyl-benzooxazol-6-ol；2-(methylthio)benzo[d]oxazol-6-ol；2-methylsulfanyl-1,3-benzoxazol-6-ol
• CAS: 74537-54-5
• 化学式: C₈H₇NO₂S
• 分子量: 181.215
• InChiKey: BCOJXXZDDAFOGZ-UHFFFAOYSA-N

物化性质

• 沸点：
  349.3±34.0 °C(Predicted)
• 密度：
  1.42±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  71.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-hydroxy-2-methylmercaptobenzoxazole 生成 6-[2-[1-(6-Methylpyridazin-3-yl)-4-piperidyl]ethoxy]-2-propoxy-1,3-benzoxazole
  参考文献：
  名称：

  2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder

  摘要：

  A series of pyridazinylpiperidinyl capsid-binding compounds with novel bicyclic substituents were synthesized and screened against human rhinovirus (HRV). Several 2-alkoxy- and 2-alkylthio-benzoxazole and benzothiazole derivatives showed excellent anti-HRV activity. When tested against a panel of 16 representative HRV types the 2-ethoxybenzoxazole derivative 13 was found to have superior HRV activity (median EC50 3.88 ng/mL) to known capsid-binders Pleconaril and Pirodavir. Compound 13 illustrates that a 2-alkoxybenzoxazole group can be an effective bioisostere for a benzoate ester or benzaldehyde oxime ether functionality. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.02.054
• 作为产物：
  描述：

  4-氨基苯-1,3-二醇 在 碳酸氢钠 作用下， 生成 6-hydroxy-2-methylmercaptobenzoxazole
  参考文献：
  名称：

  2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder

  摘要：

  A series of pyridazinylpiperidinyl capsid-binding compounds with novel bicyclic substituents were synthesized and screened against human rhinovirus (HRV). Several 2-alkoxy- and 2-alkylthio-benzoxazole and benzothiazole derivatives showed excellent anti-HRV activity. When tested against a panel of 16 representative HRV types the 2-ethoxybenzoxazole derivative 13 was found to have superior HRV activity (median EC50 3.88 ng/mL) to known capsid-binders Pleconaril and Pirodavir. Compound 13 illustrates that a 2-alkoxybenzoxazole group can be an effective bioisostere for a benzoate ester or benzaldehyde oxime ether functionality. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.02.054

文献信息

• 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING
  申请人：Sutton C James

  公开号：US20080045528A1

  公开（公告）日：2008-02-21

  Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.

  苯并噁唑和苯并噻唑化合物及其立体异构体、互变异构体、溶剂合物、氧化物、酯类和前药以及其药学上可接受的盐已被披露。所述化合物的组合物，无论是单独使用还是与至少一种额外治疗剂组合，并与药学上可接受的载体一起使用的用途也已被披露。这些实施例可用于抑制细胞增殖，抑制肿瘤的生长和/或交换反应，治疗或预防癌症，治疗或预防类风湿性关节炎等退行性骨病，以及/或抑制CSF-1R等分子。
• Antiviral agents
  申请人：——

  公开号：US20040077633A1

  公开（公告）日：2004-04-22

  This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals as well as novel intermediates useful in the preparation of the compounds of formula I. 1

  这项发明涉及公式I的化合物及其盐，以及药学上可接受的衍生物，包括这些化合物的药物组合物以及它们在治疗哺乳动物的小RNA病毒感染中的用途，以及在制备公式I化合物中有用的新型中间体。
• Purine Analogues as Amplifiers of Phleomycin. V. Thioethers of Several Heterocyclic Systems with One or Two Rings
  作者：DJ Brown、GW Grigg、Y Iwai、KN McAndrew、T Nagamatsu、Rv Heeswyck

  DOI：10.1071/ch9792713

  日期：——

  Thioethers, appropriate for testing as amplifiers of phleomycin against in vitro cultures of Escherichia coli, are prepared via corresponding thiones in the purine, imidazo[4,5-b(and 4,5-c)]pyridine, pyrazolo[3,4-d]pyrimidine, quinazoline, benzothiazole, benzoxazole, pyrimidine, imidazole, thiazoline, 1,2,4-triazole, s-triazolo[4,3-c(and 1,5-c)]pyrimidine, oxazolo[4,5-b]pyridine, quinoline and 1,3,5-triazine series. Structures are confirmed by N.M.R. spectra. Biological activities are tabulated and discussed in terms of structure.

  硫醚，适合 硫代硫醚 体外培养大肠杆菌的扩增剂、 通过嘌呤、咪唑并[4,5-b(和 4,5-c)]吡啶中的相应硫醚制备、 吡唑并[3,4-d]嘧啶、喹唑啉、苯并噻唑、苯并恶唑、嘧啶、 咪唑、噻唑啉、1,2,4-三唑、s-三唑并[4,3-c（和 1,5-c）]嘧啶、 噁唑并[4,5-b]吡啶、喹啉和 1,3,5-三嗪系列。结构 通过 N.M.R.光谱确认。生物活性表 结构进行了讨论。
• [EN] ANTIVIRAL AGENTS<br/>[FR] AGENTS ANTIVIRAUX
  申请人：BIOTA SCIENT MANAGEMENT

  公开号：WO2002050045A1

  公开（公告）日：2002-06-27

  This invention relates to compounds of formula I their salts, and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions comprising these compounds and their use in the treatment of picornavirus infections in mammals as well as novel intermediates useful in the preparation of the compounds of formula I.

  本发明涉及公式I的化合物及其盐，以及药学上可接受的衍生物，包括这些化合物的制药组合物和它们在哺乳动物的小肠病毒感染治疗中的应用，以及制备公式I化合物的新中间体。
• 6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling
  申请人：Sutton James C.

  公开号：US20120225861A1

  公开（公告）日：2012-09-06

  Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.

  公开了苯并噻唑化合物和苯并噻唑类化合物的立体异构体、互变异构体、溶剂化物、氧化物、酯和前药及其药学上可接受的盐。还公开了这些化合物的组合物，其可以与至少一种额外的治疗剂一起使用，并与药学上可接受的载体结合使用。这些实施例对于抑制细胞增殖、抑制肿瘤的生长和/或代谢、治疗或预防癌症、治疗或预防退化性骨疾病如类风湿性关节炎以及/或抑制CSF-1R等分子具有用途。